Last10K.com

Cme Group Inc. (CME) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

SEC Filings

CME Quarterly Reports

Cme Group Inc.

CIK: 1156375 Ticker: CME





                                             Exhibit 99.1
cmegpressreleasea02a.jpg
Media contactInvestor contact
Chris Grams, 312.930.3435John Peschier, 312.930.8491
Laurie Bischel, 312.648.8698CME-G
news@cmegroup.com
www.cmegroup.mediaroom.com

FOR IMMEDIATE RELEASE
CME Group Inc. Reports First-Quarter 2022 Financial Results
    CHICAGO, April 27, 2022 - CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2022.
    The company reported revenue of $1.3 billion and operating income of $859 million for the first quarter of 2022. Net income was $711 million and diluted earnings per share were $1.95. On an adjusted basis, net income was $766 million and diluted earnings per share were $2.11. Financial results presented on an adjusted basis for the first quarter of 2022 and 2021 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1
    "During this period of extreme geopolitical and economic uncertainty, our continued focus on helping clients manage their risk resulted in strong earnings and revenue growth during the first quarter," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Average daily volume was robust with double-digit increases in equity index, interest rate and options products, as well as significant volume outside the U.S. In addition, we are pleased with the accelerated growth of our SOFR futures and options since the start of the year, including record quarterly volume and open interest. Looking ahead, we will continue to provide the benchmark products, services and data our clients need as they continue to navigate through evolving central bank policies, inflation, supply chain constraints and other economic challenges."
First-quarter 2022 average daily volume (ADV) was 25.9 million contracts, including non-U.S. ADV of 7.3 million contracts, led by 28% growth in Latin America, 22% in Asia and 17% in EMEA.










1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.

- more -


The following information was filed by Cme Group Inc. (CME) on Wednesday, April 27, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Cme Group Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cme Group Inc..

Continue

Assess how Cme Group Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cme Group Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Other
Filter Subcategory:
All
Income
Product
Earnings
Expense
Dividend
Shares
Geography
Other
Inside Cme Group Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Consolidated Statements Of Shareholders' Equity
Consolidated Statements Of Shareholders' Equity (Parenthetical)
Accounting Policies (Policies)
Accumulated Other Comprehensive Income (Details)
Accumulated Other Comprehensive Income (Notes)
Accumulated Other Comprehensive Income (Tables)
Basis Of Presentation
Basis Of Presentation (Details)
Contingencies
Debt
Debt (Schedule Of Maturities Of Long-Term Debt) (Details)
Debt (Schedule Of Short-Term And Long-Term Debt) (Details)
Debt (Tables)
Debt Narrative (Details) (Details)
Earnings Per Share
Earnings Per Share (Narrative) (Details)
Earnings Per Share (Net Income Attributable To Cme Group) (Details)
Earnings Per Share (Tables)
Fair Value Measurements
Fair Value Measurements (Estimated Fair Values Of Long-Term Debt) (Details)
Fair Value Measurements (Financial Instruments Measured At Fair Value On A Recurring Basis) (Details)
Fair Value Measurements (Narrative) (Details)
Fair Value Measurements (Tables)
Guarantees
Guarantees (Details)
Intangible Assets And Goodwill
Intangible Assets And Goodwill (Components Of Goodwill) (Details)
Intangible Assets And Goodwill (Components Of Intangible Assets) (Details)
Intangible Assets And Goodwill (Future Estimated Amortization Expense) (Details)
Intangible Assets And Goodwill (Narrative) (Details)
Intangible Assets And Goodwill (Tables)
Leases (Details)
Leases (Notes)
Leases (Tables)
Leases Capital Leases, Future Minimum Payments Due (Details)
Leases Lease Costs (Details)
Leases Operating Leases Future Minimum Payments (Details)
Leases Supplemental Balance Sheet Information-Leases (Details)
Leases Supplemental Cash Flow Information-Leases (Details)
Performance Bonds And Guaranty Fund Contributions (Details)
Performance Bonds And Guaranty Fund Contributions (Notes)
Revenue Recognition (Details)
Revenue Recognition (Notes)
Revenue Recognition (Tables)
Revenue Recognition Disaggregation Of Revenue (Details)
Subsequent Events (Notes)

Material Contracts, Statements, Certifications & more

Cme Group Inc. provided additional information to their SEC Filing as exhibits

Ticker: CME
CIK: 1156375
Form Type: 10-Q Quarterly Report
Accession Number: 0001156375-22-000158
Submitted to the SEC: Wed May 04 2022 12:30:22 PM EST
Accepted by the SEC: Wed May 04 2022
Period: Thursday, March 31, 2022
Industry: Security And Commodity Brokers Dealers Exchanges And Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cme/0001156375-22-000158.htm